These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16887605)

  • 41. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo antibacterial evaluation of DRF 8417, a new oxazolidinone.
    Sreenivas K; Amarnath PV; Mallik A; Sarnaik H; Kumar NS; Takhi M; Trehan S; Kumar MS; Iqbal J; Rajagopalan R; Chakrabarti R
    J Antimicrob Chemother; 2007 Jul; 60(1):159-61. PubMed ID: 17449889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
    Biedenbach DJ; Ross JE; Fritsche TR; Sader HS; Jones RN
    J Clin Microbiol; 2007 Mar; 45(3):998-1004. PubMed ID: 17215346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antimicrobial activity of propolis samples from different geographical origins against certain oral pathogens.
    Koru O; Toksoy F; Acikel CH; Tunca YM; Baysallar M; Uskudar Guclu A; Akca E; Ozkok Tuylu A; Sorkun K; Tanyuksel M; Salih B
    Anaerobe; 2007; 13(3-4):140-5. PubMed ID: 17475517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro susceptibility of anaerobic bacteria to nitroimidazoles.
    Olsson-Liljequist B; Nord CE
    Scand J Infect Dis Suppl; 1981; 26():42-5. PubMed ID: 6941455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial activity of selected plant species from "the Argentine Puna" against sensitive and multi-resistant bacteria.
    Zampini IC; Cuello S; Alberto MR; Ordoñez RM; D' Almeida R; Solorzano E; Isla MI
    J Ethnopharmacol; 2009 Jul; 124(3):499-505. PubMed ID: 19467313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.
    Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez H
    Antimicrob Agents Chemother; 2006 Jan; 50(1):148-55. PubMed ID: 16377680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A longitudinal analysis of antimicrobial susceptibility in clinical institutions in Germany as part of the Tigecycline Evaluation and Surveillance Trial (2004-2007).
    Seifert H; Dowzicky MJ
    Chemotherapy; 2009; 55(4):241-52. PubMed ID: 19468222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria.
    Liu J; He B; Yu A; Zhou W
    Chem Biol Drug Des; 2007 Apr; 69(4):265-8. PubMed ID: 17461974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of a novel carbapenem, doripenem, against anaerobic pathogens.
    Goldstein EJ; Citron DM
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):447-54. PubMed ID: 19249176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study.
    Boyanova L; Vladimir Djambazov ; Gergova G; Dragomir Iotov ; Petrov D; Osmanliev D; Minchev Z; Mitov I
    Anaerobe; 2004 Oct; 10(5):261-7. PubMed ID: 16701526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
    Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF
    J Antimicrob Chemother; 2008 Jul; 62(1):116-21. PubMed ID: 18424792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
    Anastasiou DM; Thorne GM; Luperchio SA; Alder JD
    Int J Antimicrob Agents; 2006 Nov; 28(5):385-8. PubMed ID: 17046205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linezolid in the treatment of brain abscess due to Peptostreptococcus.
    Salin F; Vianello F; Manara R; Morelli E; Cattelan A; Scarin M; Sgarabotto D
    Scand J Infect Dis; 2006; 38(3):203-5. PubMed ID: 16500781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New oxazolidinones.
    Vara Prasad JV
    Curr Opin Microbiol; 2007 Oct; 10(5):454-60. PubMed ID: 17928263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria.
    Citron DM; Warren YA; Tyrrell KL; Merriam V; Goldstein EJ
    J Antimicrob Chemother; 2009 May; 63(5):972-6. PubMed ID: 19240076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
    Gómez-Garcés JL; Alos JI; Tamayo J
    Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
    Jones RN; Fritsche TR; Sader HS; Ross JE
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):309-17. PubMed ID: 17720350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.